Enzo Diagnostics has been awarded US Patent No. 8,445,664, "Kits for amplifying and detecting nucleic acid sequences."
Elazar Rabbani, Jannis Stavrianopoulos, James Donegan, Jack Coleman, and Marleen Walter are named as inventors.
Beckman said the closing payment for the deal would fixed at $780 million. It also said that it would eliminate Olympus' immunoassay product line and related R&D efforts after the closing of the deal.
The $800 million acquisition will strengthen Beckman Coulter's presence in the clinical chemistry market. The firm does not anticipate a change in its current investment grade ratings due to the new debt.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.
